Cargando…
Medication Risk-Taking Behavior in Functional Dyspepsia Patients
OBJECTIVES: No medication is approved for the treatment of functional dyspepsia (FD). The risks that patients would be willing to take to cure their FD symptoms are unknown. METHODS: FD patients (Rome III criteria) were mailed a questionnaire that assessed demographics, medication use, and prior med...
Autores principales: | Lacy, Brian E, Yu, Jerry, Crowell, Michael D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418407/ https://www.ncbi.nlm.nih.gov/pubmed/25569188 http://dx.doi.org/10.1038/ctg.2014.18 |
Ejemplares similares
-
Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia
por: Ishigami, Hideaki, et al.
Publicado: (2017) -
Delayed Intracranial Hemorrhage in Patients Taking Warfarin with Head Trauma
por: Macedo, Mark, et al.
Publicado: (2017) -
Take of the Leaven of Damnation
por: Pratt, Ben. H.
Publicado: (1880) -
Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)
por: Taylor, Fiona, et al.
Publicado: (2018) -
Eating Behavior in Functional Dyspepsia
por: Choe, Younghee, et al.
Publicado: (2022)